You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
南京醫藥(600713.SH):以8085萬元轉讓鶴齡藥事49%股權予江蘇弘景
格隆匯 03-03 16:13

格隆匯3月3日丨南京醫藥(600713.SH)公佈,公司的控股子公司南京藥業與江蘇弘景簽訂《產權交易合同》,轉讓南京藥業持有的全資子公司南京鶴齡藥事服務有限公司(以下簡稱“鶴齡藥事”)49%股權,轉讓價格為8085萬元人民幣。

鶴齡藥事通過本次混合所有制改革引入戰略投資者,吸引中醫藥產業鏈資源方賦能公司中藥藥事服務創新業務發展,傳承中醫藥文化,發展自有品牌,打造大健康產業鏈,加快“智能化”中藥湯劑煎煮基地,配合中醫藥文化健康產業基地建設,利用科技和互聯網技術打造線上線下並重的中藥藥事服務平台以推進建立“醫患直通”模式,深化拓展鶴齡藥事在等級醫院及基層醫療市場業務,繼續鞏固區域中藥藥事服務創新模式標準化引領示範,進一步聚焦核心資源提升整體運營質量和盈利水平,為公司發展培育新增長點。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account